While research and therapies have typically focused on the deleterious angiotensin II axis of the renin–angiotensin system, emerging evidence shows that targeting the protective angiotensin-(1-7) axis also improves cardiovascular and metabolic functions in animal models of obesity hypertension. The gene discussed is AGT; the disease is Hypertension.